In a groundbreaking achievement for global public health and biotechnology, the Reference and Surveillance Intelligence Department (RASID) at the Central Testing Laboratory of the Abu Dhabi Quality and Conformity Council, in partnership with M42, has announced a significant scientific milestone. As reported by **Business Promotion24**, the team successfully detected and isolated a recently identified and rare genetic clade of *Candida auris*—a highly resistant fungal pathogen—through Abu Dhabi’s advanced wastewater early surveillance system.
### A Regional First in Scientific Research
The study, which has been published in the prestigious journal *Communications Medicine* (part of the Nature Portfolio), marks the first known regional detection of *Candida auris* Clade VI via environmental surveillance. This discovery is pivotal, as it enhances the global scientific understanding of the pathogen’s genetic diversity and provides a roadmap for assessing emerging health risks before they reach a critical stage in clinical settings.
The World Health Organization (WHO) currently classifies *Candida auris* within the ‘Critical Priority Group’ of fungal pathogens due to its multi-drug resistance and the high difficulty of controlling it in healthcare environments.
### Advanced Methodology: Beyond Genetic Traces
The success of this study was rooted in a massive data set involving more than 23,000 systematically collected wastewater samples. Unlike standard tests that merely identify genetic fragments, the RASID and M42 researchers successfully isolated the live fungus directly from the samples.
The scientific methodology employed was rigorous, including:
* **Whole Genome Sequencing (WGS):** To map the genetic blueprint of the isolates.
* **Phylogenetic Analysis:** To determine the specific clade classification (Clade VI).
* **Antifungal Susceptibility Testing:** To investigate how the fungus reacts to existing treatments.
* **Genomic Marker Identification:** To understand the mechanisms behind its resistance.
### The Power of Environmental Surveillance
Samara Bin Salem, Director of RASID, highlighted that the value of this achievement lies in the ability to transform environmental data into actionable intelligence. By combining laboratory isolation with genomic science, the team can now understand population-level changes and emerging risks with unprecedented precision.
Dr. Bhuvanesh Shanmugam, Senior Microbiologist at M42, emphasized that identifying Clade VI beyond clinical settings provides deeper insight into how these pathogens evolve. Furthermore, Dr. Grzegorz Brudecki of M42 noted that continuous surveillance allows health authorities to distinguish between “expected patterns” and “unusual signals,” enabling a proactive rather than reactive response.
### Strengthening Abu Dhabi’s Public Health System
This milestone reflects the evolution of RASID from a conventional testing laboratory into a sophisticated early-warning hub. By integrating AI-powered technology from M42 with environmental science, Abu Dhabi is setting a global standard for pandemic preparedness.
The findings provide the Department of Health – Abu Dhabi and the Abu Dhabi Public Health Centre with critical data to complement clinical information. This integrated approach ensures that the UAE remains at the forefront of medical innovation and biosafety.
For more updates on innovation and health technology, stay tuned to **Business Promotion24**, your source for the latest breakthroughs shaping our world.
